Login / Signup

The role of upfront lenalidomide maintenance for primary central nervous system lymphoma following first-line methotrexate treatment: A retrospective study.

Yan ZhangWei WangDanqing ZhaoChong WeiChao ChenWei ZhangDao-Bin Zhou
Published in: Cancer medicine (2024)
The present study was the first to evaluate lenalidomide maintenance as a frontline treatment among patients with PCNSL, PFS and OS did not improve, although the safety profile was satisfactory.
Keyphrases
  • multiple myeloma
  • newly diagnosed
  • combination therapy
  • low dose
  • cerebrospinal fluid